• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Rapid genetic testing useful for diagnosis of critically ill children

byStephanie Harlow, MDandLeah Carr, MD
September 22, 2017
in Chronic Disease, Pediatrics
Reading Time: 3 mins read
Rapid genetic testing useful for diagnosis of critically ill children
Share on FacebookShare on TwitterShare on LinkedIn

1. In a cohort of children under the age of 12 months admitted to the intensive care unit (ICU) without a clear diagnosis, rapid, targeted genetic testing revealed a diagnosis in about one-third of patients.

2. Genetic diagnoses significantly impacted the care of those children identified as having a genetic mutations, leading to removal of unnecessary treatment in a number of children.

Study Rundown: Timely diagnosis of genetic diseases in severely ill children can be difficult and lengthy, yet definitive diagnoses are often critical. In this study, researchers used rapid whole genome sequencing (WGS) to analyze specific genes as part of the diagnostic work up in infants under age 1 admitted to the ICU. This study included critically ill infants with clinical suspicion of a genetic disease, but without a clear diagnosis. Patients identified as “critically ill” included infants with cardiorespiratory insufficiency requiring a ventilator or organ dysfunction which was thought to have imminent risk for cardiorespiratory insufficiency. The team assessed diagnostic yield, speed of results, and the effect of WGS on clinical management. Variants discovered after WGS were filtered through a number of genetic databases for assessment of minor alleles, and variants remaining were evaluated manually by investigators. Of the infants included in the study, about one-third were identified as having a genetic mutation as the cause of their presenting illness. In the majority of children with identified mutations, unsuccessful intensive therapies were withdrawn following diagnosis. The study was limited by its small sample size and completion at a single center, but demonstrates the potential clinical utility of rapid WGS to efficiently diagnose suspected genetic syndromes.

Click here to read the original article, published today in Pediatrics

Relevant Reading: Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings

In-Depth [prospective pilot study]: This study assessed 23 infants under age 1 admitted to the NICU/PICU who were critically ill. Included patients lacked a definitive diagnosis, though a genetic etiology was suspected. Of those infants included, 6 presented with abnormal muscle tone, 5 with severe seizures, 4 with cardiomyopathy, 3 with liver failure, 2 with microcephaly, 1 with leukoencephalopathy-induced coma, 1 with multiple congenital anomalies, and 1 with interstitial lung disease. Measured endpoints included diagnostic yield, speed of turnaround, and clinical effect of the results. Turnaround was defined as the period of time starting when the patient was initiated into the study and ended with provisional diagnosis. After WGS was completed, specific genes were analyzed based on known clinical significance of some 3300 mutations documented in the Clinical Genome Database. Sequenced genes under investigation were assess using Human Phenotype Ontology (HPO) terms, and the presence of minor alleles was assessed using data from 5 previously established databases. Seven of the 23 infants included received a genetic diagnosis, with the turnaround time ranging from 5 to 23 days for diagnosis (median = 12). Diagnoses included Vici syndrome, combined oxidative phosphorylation deficiency-11, and vanishing white matter, nemaline myopathy, progressive mitochondrial myopathy, and GM1-gangliosidosis, and a 1p36.33p36.32 microdeletion. Five of the 7 diagnosed patients had unsuccessful care withdrawn following the identification of their underlying genetic disorder.

RELATED REPORTS

Drying prior to plastic wrapping may not provide thermoregulatory benefits in infants admitted to the neonatal intensive care unit

2 Minute Medicine Rewind April 6, 2026

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: geneticsneonatal intensive care unit (NICU)neonatologywhole genome sequencing (WGS)
Previous Post

Risk of death and cardiac arrest during triathlon may be higher in older males

Next Post

Adverse outcomes are similar for patients undergoing percutaneous coronary intervention receiving heparin or bivalirudin

RelatedReports

Stochastic resonance stimulation may decrease apnea of prematurity
Emergency

Drying prior to plastic wrapping may not provide thermoregulatory benefits in infants admitted to the neonatal intensive care unit

April 10, 2026
Stochastic resonance stimulation may decrease apnea of prematurity
Weekly Rewinds

2 Minute Medicine Rewind April 6, 2026

April 6, 2026
Contrast-enhanced computed tomography associated with high sensitivity to renal stone detection
Chronic Disease

One in three people with cystic fibrosis may experience nephrolithiasis during their life

January 15, 2026
Parents desensitized with increasing exposure to movie violence/sex
Public Health

Australian couple-based genetic screening program feasible and accepted

August 27, 2025
Next Post
Long-term outcomes for off-pump and on-pump CABG are similar

Adverse outcomes are similar for patients undergoing percutaneous coronary intervention receiving heparin or bivalirudin

Treatment of subclinical hypothyroidism ineffective in older adults

Thyrotropin and free T4 levels associated with life expectancy and risk of cardiovascular disease

Tumor-specific mutant antigens are potential targets for cancer therapy [PreClinical]

Adiponectin treats some symptoms of polycystic ovarian syndrome in mice [PreClinical]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Limited-time Deep research trial
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.